Brand & Product Security

OneScan 7.1 is expected to boost compliance, while also improving pharma supply chain efficiencies.

A look at the challenges that need to be addressed during the FDA stabilization period.

Dave DeJean provides his expert insight on lessons he’s learned from his plethora of time in the industry, along with an outlook on where the pharma supply chain stands in adhering to the Drug Supply Chain Security Act (DSCSA).

The predicted value is largely driven by manufacturers' prioritization of brand protection.

EdenHelp is expected to provide HCPs and patients with real-time access to Rx drug and medical device information.

JAMA Health Forum details the DSCSA and stresses the value of protecting the pharmaceutical supply chain from adulterated products.

This year’s PC Podcast episodes ranged in topic, from DSCSA compliance to pharmacovigilance.

Cloud-based service to address verification of saleable returns under the latest DSCSA regulations.

The seminar examines where members of the pharma supply chain stand in terms of preparation, being that the act has officially been enacted.

Back in Boston, Pharma Commerce tackles all things logistics at LogiPharma USA.

With new mandates right around the corner, there is an unwavering demand for pharma operations to perform at peak efficiency.

Value is attributed to the rise in counterfeit cases and ongoing regulations surrounding anti-counterfeit packaging.

A breakdown on the decision, and how to navigate these obstacles using a network approach.

Conference hosts roundtable chats, with topics ranging from data-driven decision making to cold chain logistics.

Tracy Nasarenko offers her final thoughts on DSCSA implementation guidelines at LogiPharma USA 2023.

Sr. Director of Community Engagement for Pharmaceuticals at GS1 US explains what the implementation guidelines are meant to accomplish.

GS1 US Executive provides insight on how pharma supply can speed up the process of complying with regulations.

In an interview at LogiPharma USA 2023 with Pharma Commerce Editor Nicholas Saraceno, Tracy Nasarenko, Sr. Director of Community Engagement for Pharmaceuticals, GS1 US highlights her “DSCSA—Final Checks to Have Before Deadlines.”

LogiPharma session reminds attendees of what to review, as far as DSCSA compliance is concerned.

Pharma Commerce converges on Nation's Capital for HDA Traceability Seminar.

Questions and considerations for pharmaceutical companies in designing and executing strategies to curb the incidence of fake drugs.

Stakeholders uncover the obstacles surrounding the industry onboarding process.

Attendees meet to discuss operational issues related to traceability implementation.

Session offers information on industry readiness, plus an overview of a phase implementation recommendation.

Event’s first session aims to analyze the legislation’s implementation, as FDA enforcement is delayed until November 2024.